5-Morpholinopicolinonitrile

Catalog No.: 
ACJXUE887
CAS No.: 
1156520-22-7
Molecular Formula: 
C10H11N3O
Molecular Weight: 
189.22
5-Morpholinopicolinonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$130.00InquiryInquiry
100mg98%$184.00InquiryInquiry
250mg98%$254.00InquiryInquiry
1g98%$497.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Morpholinopicolinonitrile
IUPAC Name5-morpholinopicolinonitrile
MDL No.MFCD12022272
Molecular FormulaC10H11N3O
Molecular Weight189.22
SMILESN#CC1=NC=C(N2CCOCC2)C=C1
InChI KeyIZIOVIKPDZOZPI-UHFFFAOYSA-N
Synonym5-Morpholinopicolinonitrile;5-(4-morpholinyl)-2-pyridinecarbonitrile;2-Pyridinecarbonitrile, 5-(4-morpholinyl)-;5-(Morpholin-4-yl)pyridine-2-carbonitrile
CAS No.1156520-22-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACJXUE887 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXPTW024 route compound structure diagram
    ACXPTW024327056-62-2In Stock
  4. Then
  5. ACJXUE887 route product structure diagram
    ACJXUE8871156520-22-7
Inquiry

2. ACJXUE887 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJXUE887 route product structure diagram
    ACJXUE8871156520-22-7
Inquiry

3. ACJXUE887 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJXUE887 route product structure diagram
    ACJXUE8871156520-22-7
Inquiry

Comments (0)